DA Davidson Downgrades Medifast (MED) to Underperform

June 5, 2024 6:07 AM EDT Send to a Friend
DA Davidson analyst Linda Bolton Weiser downgraded Medifast (NYSE: MED) from Neutral to Underperform with a price target of $17.50 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login